ID   BIONi010-B
AC   CVCL_1E67
SY   K2_shp53; K2P53
DR   BioSamples; SAMEA3158000
DR   EBiSC; BIONi010-B
DR   ECACC; 66540030
DR   EGA; EGAS00001002755
DR   GEO; GSM1183106
DR   hPSCreg; BIONi010-B
DR   SKIP; SKIP002535
DR   Wikidata; Q54796747
RX   PubMed=25241739;
RX   PubMed=27596958;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: African.
CC   Omics: Genome sequenced.
CC   Omics: Transcriptome analysis by microarray.
CC   Discontinued: ECACC; 66540030; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1E66 ! BIONi010-A
OI   CVCL_1E68 ! BIONi010-C
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 16
//
RX   PubMed=25241739; DOI=10.1016/j.stemcr.2014.07.006;
RA   Rasmussen M.A., Holst B., Tumer Z., Johnsen M.G., Zhou S.-L.,
RA   Stummann T.C., Hyttel P., Clausen C.;
RT   "Transient p53 suppression increases reprogramming of human
RT   fibroblasts without affecting apoptosis and DNA damage.";
RL   Stem Cell Reports 3:404-413(2014).
//
RX   PubMed=27596958; DOI=10.1016/j.scr.2016.07.004;
RA   Hansen S.K., Stummann T.C., Borland H., Hasholt L.F., Tumer Z.,
RA   Nielsen J.E., Rasmussen M.A., Nielsen T.T., Daechsel J.C.A., Fog K.,
RA   Hyttel P.;
RT   "Induced pluripotent stem cell-derived neurons for the study of
RT   spinocerebellar ataxia type 3.";
RL   Stem Cell Res. 17:306-317(2016).
//